Group 1 - The stock price of Shengda Bio reported at 18.64 yuan as of August 18, 2025, with a decrease of 0.14 yuan, representing a decline of 0.75% from the previous trading day [1] - The company specializes in the research, production, and sales of biotin, folic acid, and other vitamin products, which are widely used in feed, food, and pharmaceutical industries [1] - Shengda Bio's industry classification falls under the chemical products sector, involving synthetic biology and vitamins concepts [1] Group 2 - Shengda Bio announced the redemption of structured deposits amounting to 80 million yuan, which matured on August 15, resulting in a total recovery of 80.1193 million yuan, aligning with expected returns [1] - On August 18, the net outflow of main funds was 6.7311 million yuan, with a cumulative net outflow of 17.9616 million yuan over the past five days [1]

Core Viewpoint - The stock price of Shengda Bio as of August 5, 2025, is 18.35 yuan, reflecting a decrease of 0.49% from the previous trading day, with a trading volume of 0.77 billion yuan and a turnover rate of 2.44% [1] Company Overview - Shengda Bio specializes in the research, production, and sales of biotin, folic acid, and other vitamin products, which are widely used in feed, food, and pharmaceutical industries [1] - The company operates in sectors including chemical products, synthetic biology, and vitamins [1] Financial Performance - Shengda Bio expects a net profit attributable to shareholders of the listed company for the first half of 2025 to be between 35 million yuan and 45 million yuan, representing a year-on-year growth of 112.19% to 172.81% [1] Capital Flow - On August 5, 2025, the net outflow of main funds was 16.8795 million yuan, with a cumulative net outflow of 37.7823 million yuan over the past five days [1]